Tissue-specific responses of IGF-1/insulin and mTOR signaling in calorie restricted rats.

Naveen Sharma, Carlos M Castorena, Gregory D Cartee
Author Information
  1. Naveen Sharma: Muscle Biology Laboratory, School of Kinesiology, University of Michigan, Ann Arbor, Michigan, United States of America.

Abstract

Moderate calorie restriction (CR) (∼60% of ad libitum, AL, intake) has been associated with numerous favorable physiological outcomes in many species, and the insulin/IGF-1 and mTOR signaling pathways have each been proposed as potential mediators for many of CR's bioeffects. However, few studies have assessed the widely held idea that CR induces the down-regulation of the insulin/IGF-1 and/or mTOR pathways in multiple tissues. Accordingly, we analyzed the phosphorylation status of 11 key signaling proteins from the insulin/IGF-1 (IR(Tyr1162/1163), IGF-1R(Tyr1135/1136), IRS-1(Ser312), PTEN(Ser380), Akt(Ser473), GSK3α(Ser21), GSK3β(Ser9)) and mTOR (TSC2(Ser939), mTOR(Ser2448), P70S6K(Thr412), RPS6(Ser235/236)) pathways in 11 diverse tissues [liver, kidney, lung, aorta, two brain regions (cortex and cerebellum), and two slow-twitch and three fast-twitch skeletal muscles] from 9-month-old male AL and CR Fischer 344 x Brown Norway rats. The rats were studied under two conditions: with endogenous insulin levels (i.e., AL>CR) and with insulin infused during a hyperinsulinemic-euglycemic clamp so that plasma insulin concentrations were matched between the two diet groups. The most striking and consistent effect of CR was greater pAkt in 3 of the 5 skeletal muscles of CR vs. AL rats. There were no significant CR effects on the mTOR signaling pathway and no evidence that CR caused a general attenuation of mTOR signaling across the tissues studied. Rather than supporting the premise of a global downregulation of insulin/IGF-1 and/or mTOR signaling in many tissues, the current results revealed clear tissue-specific CR effects for the insulin signaling pathway without CR effects on the mTOR signaling pathway.

References

  1. Sci Am. 1996 Jan;274(1):46-52 [PMID: 8533065]
  2. Biochem Soc Trans. 2011 Apr;39(2):460-5 [PMID: 21428920]
  3. Am J Physiol Endocrinol Metab. 2011 Jun;300(6):E966-78 [PMID: 21386065]
  4. Philos Trans R Soc Lond B Biol Sci. 2011 Jan 12;366(1561):17-27 [PMID: 21115526]
  5. Diabetes. 1999 Oct;48(10):1930-6 [PMID: 10512356]
  6. Toxicol Sci. 1999 Dec;52(2 Suppl):35-40 [PMID: 10630588]
  7. Diabetes. 2009 Jul;58(7):1488-98 [PMID: 19336678]
  8. Cell Mol Life Sci. 2005 Feb;62(3):320-43 [PMID: 15723168]
  9. Biochim Biophys Acta. 2011 Nov;1813(11):1965-70 [PMID: 21440577]
  10. Exp Gerontol. 2005 Jan-Feb;40(1-2):27-35 [PMID: 15664729]
  11. Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E693-700 [PMID: 12799317]
  12. Biochim Biophys Acta. 2009 Oct;1790(10):1067-74 [PMID: 19539012]
  13. Am J Physiol. 1998 Dec;275(6):E957-64 [PMID: 9843737]
  14. Nature. 2009 Jul 16;460(7253):392-5 [PMID: 19587680]
  15. Am J Physiol Endocrinol Metab. 2002 Feb;282(2):E270-6 [PMID: 11788357]
  16. Am J Physiol. 1999 Apr;276(4):E728-38 [PMID: 10198310]
  17. PLoS One. 2009;4(2):e4567 [PMID: 19234595]
  18. Cell Cycle. 2010 Feb 15;9(4):683-8 [PMID: 20139716]
  19. Aging Cell. 2009 Sep;8(5):607-13 [PMID: 19678809]
  20. FEBS Lett. 2005 Jul 4;579(17):3632-8 [PMID: 15961082]
  21. J Gerontol A Biol Sci Med Sci. 1999 Nov;54(11):B492-501 [PMID: 10619312]
  22. Aging Cell. 2010 Apr;9(2):105-12 [PMID: 20096035]
  23. Am J Physiol Endocrinol Metab. 2005 May;288(5):E996-E1001 [PMID: 15613677]
  24. Curr Opin Cell Biol. 2011 Dec;23(6):744-55 [PMID: 21963299]
  25. J Neurochem. 2010 Nov;115(4):974-83 [PMID: 20831597]
  26. Nature. 2009 Jul 16;460(7253):331-2 [PMID: 19606132]
  27. J Gerontol A Biol Sci Med Sci. 2010 Jun;65(6):580-9 [PMID: 20083554]
  28. J Endocrinol. 2009 Dec;203(3):337-47 [PMID: 19801385]
  29. EMBO J. 2005 Apr 20;24(8):1571-83 [PMID: 15791206]
  30. Acta Physiol Scand. 2000 Jun;169(2):133-9 [PMID: 10848643]
  31. J Mol Cell Biol. 2010 Feb;2(1):17-9 [PMID: 19805415]
  32. Cell Metab. 2010 Jun 9;11(6):453-65 [PMID: 20519118]
  33. Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35 [PMID: 21157483]
  34. Mol Aspects Med. 2011 Jun;32(3):159-221 [PMID: 21840335]
  35. Cell Signal. 2008 Jan;20(1):206-18 [PMID: 17993264]
  36. Diabetes. 2005 May;54(5):1349-56 [PMID: 15855319]
  37. Mech Ageing Dev. 2005 Sep;126(9):913-22 [PMID: 15885745]
  38. J Biol Chem. 2006 Oct 13;281(41):30479-84 [PMID: 16912034]
  39. J Biol Chem. 2007 Feb 9;282(6):3904-17 [PMID: 17148450]
  40. Best Pract Res Clin Endocrinol Metab. 2004 Sep;18(3):393-406 [PMID: 15261845]

Grants

  1. R01 AG010026/NIA NIH HHS
  2. AG-013283/NIA NIH HHS
  3. T32 GM008322/NIGMS NIH HHS
  4. AG-010026/NIA NIH HHS
  5. P30 DK020572/NIDDK NIH HHS
  6. P30 AG013283/NIA NIH HHS

MeSH Term

Analysis of Variance
Animals
Caloric Restriction
Down-Regulation
Electrophoresis, Polyacrylamide Gel
Glucose Clamp Technique
Immunoblotting
Insulin
Insulin-Like Growth Factor I
Male
Metabolic Networks and Pathways
Muscle, Skeletal
Phosphorylation
Rats
Signal Transduction
TOR Serine-Threonine Kinases

Chemicals

Insulin
Insulin-Like Growth Factor I
mTOR protein, rat
TOR Serine-Threonine Kinases

Word Cloud

Created with Highcharts 10.0.0CRmTORsignalinginsulin/IGF-1tissuestworatsinsulinALmanypathwayseffectspathwaycalorieand/or11skeletalstudiedModeraterestriction∼60%adlibitumintakeassociatednumerousfavorablephysiologicaloutcomesspeciesproposedpotentialmediatorsCR'sbioeffectsHoweverstudiesassessedwidelyheldideainducesdown-regulationmultipleAccordinglyanalyzedphosphorylationstatuskeyproteinsIRTyr1162/1163IGF-1RTyr1135/1136IRS-1Ser312PTENSer380AktSer473GSK3αSer21GSK3βSer9TSC2Ser939Ser2448P70S6KThr412RPS6Ser235/236diverse[liverkidneylungaortabrainregionscortexcerebellumslow-twitchthreefast-twitchmuscles]9-month-oldmaleFischer344xBrownNorwayconditions:endogenouslevelsieAL>CRinfusedhyperinsulinemic-euglycemicclampplasmaconcentrationsmatcheddietgroupsstrikingconsistenteffectgreaterpAkt35musclesvssignificantevidencecausedgeneralattenuationacrossRathersupportingpremiseglobaldownregulationcurrentresultsrevealedcleartissue-specificwithoutTissue-specificresponsesIGF-1/insulinrestricted

Similar Articles

Cited By